Buy Like Buffett
Watchlist

TANKE BIOSCIENCES CORP

TNBI · Consumer Staples · $266482 mkt cap · FY2012 filings · Shallow moat ·

Doesn't clear the bar

Shallow moat
Share / Embed this score
Embed this score

The five investor questions

50

2010–2011 (latest 2 aligned FYs; v3 window cap 5): revenue $20.1M to $23.8M, increasing; diluted EPS 0.34 to -0.24, decreasing. Two-year history is scoreable but carries less confidence than a full-cycle record.

64

Median gross margin 36.8% over 3y, very stable.

100

Median ROIC 25.3%, above the 12% hurdle in 100% of years.

58

Net cash position — no leverage risk.

24

Owner earnings changed trend unclear over up to the ten most recent annual observations.

Price vs. value if growth stopped today

A cautious baseline, not a price target: what the shares may support if normalized owner earnings simply hold steady.

Above value if growth stopped todayBelow value if growth stopped today
No price data
Not reported
Unavailable — insufficient owner-earnings data
Unavailable — insufficient growth-model data
$0.02
No price data

This zero-growth estimate assumes trailing owner earnings persist — unreliable for declining businesses. Flag status unavailable — four adjacent recent FY revenue observations are required.

Model details under moat-index@3.0.0: zero-growth multiple 11.1×, capped-growth comparison at no more than 18×; 9% discount rate; high-end growth 0% (capped at 4%) using min(5y revenue CAGR, 5y diluted-EPS CAGR), clamped to 0%–4%; maintenance capex uses min(capex, D&A); abstain when D&A is unavailable. This is a disclosed model range, not intrinsic value as fact.

5 years of fundamentals

The business, in plain English

TANKE BIOSCIENCES CORP booked $28.6M of revenue in FY2012 in the Consumer Staples sector and kept 34.8% of it as gross profit — a moderate-margin business by that measure. After every other cost, −0.7% of each revenue dollar reached the bottom line.

It earned 25.3% on invested capital in the latest filed year, FY2012. Across the full 3-year measurable filed record, median ROIC was 25.3%. Over the v3 recent window (3 measurable filed years), median ROIC was 25.3%. The Returns on Capital filter above scores it 100/100.

The balance sheet carried $2.1M of total debt in FY2012. Balance-Sheet Safety scores it 58/100.

Put together: Returns on Capital is the strongest of the five filters (100/100) and Capital Allocation the weakest (24/100), which is how TNBI lands at 59/100 — a Shallow moat.

This breakdown is generated from the filed numbers and sub-scores above — no outside narrative, no estimates. Where a filing doesn’t disclose an input, the sentence that would need it is omitted instead of guessed.

FY2008–FY2012 · 5 fiscal years, normalized from TNBI’s SEC filings

Sales, as filed$28.6M FY2012
$0$20M200820102012
Revenue kept after cost of goods34.8% FY2012
0%20%200820102012
Standard ROIC or separately labeled Operating ROICROIC 25.3% FY2012
0%20%40%200820102012
Cash an owner could take out−$210247 FY2012
−$2.5M$0$2.5M200820102012

Gaps in a line mean that item isn’t in TNBI’s filings for that year. The series is never interpolated or estimated. The Table view lists every filed value, including operating and net margins, total debt, and share count.

Flagship explainer

How TANKE BIOSCIENCES CORP makes its money

Start with a dollar of revenue and follow what the filing says remains.

revenueBranching filed flows with values and percentages directly labeled. Missing filing concepts are omitted rather than estimated.Revenue$28.6M · 100%Cost of revenue$18.6M · 65%Gross profit$9.9M · 35%Operating income$4.5M · 16%Income before tax$602591 · 2%Income tax$831597 · 3%Net income−$210247 · −1%As of 2012-12-31 · 1 SEC filing sourceBuy Like Buffett · buylikebuffett.com

Honest partial: the filing did not provide a normalized tag for Research and development, Selling, general and administrative; those components are omitted, not plugged.

Table alternative
Filed lineValue% of revenueSource
$28.6M100%
Cost of revenue$18.6M65%
$9.9M35%
$4.5M16%
Income before tax$6025912%
Income tax$8315973%
−$210247−1%
Source: · event Dec 31, 2012 · retrieved Jul 26, 2026 · annual-row source set
Embed this chart

Flagship explainer

What TANKE BIOSCIENCES CORP owns — and owes

TANKE BIOSCIENCES CORP's filing tags don't support a full breakdown — here's what is filed:

Table alternative
Filed lineValue% of assetsSource
Total assets$28.8M100%
Cash and equivalents$6.2M21%
$2.1M7%
Stockholders’ equity$15.8M55%
Source: · event Dec 31, 2012 · retrieved Jul 26, 2026 · annual-row source set

Flagship explainer

What drives TANKE BIOSCIENCES CORP’s return on equity?

ROE is five filed business factors multiplied together.

DuPont return on equity factor treeReturn on equity branches into tax burden, interest burden, operating margin, asset turnover, and the equity multiplier.Return on equity−1%Tax burden−35%net income ÷ pretax incomeInterest burden13%pretax ÷ operating incomeOperating margin16%operating income ÷ revenueAsset turnover1.06×revenue ÷ average assetsEquity multiplier1.70×average assets ÷ average equityAs of 2012-12-31 · 2 SEC filing sourcesBuy Like Buffett · buylikebuffett.com
DuPont source inputs
InputValueFiscal yearSource
−$210247FY2012
Income before tax$602591FY2012
Operating income$4.5MFY2012
$28.6MFY2012
Ending assets$28.8MFY2012
Beginning assets$24.9MFY2011
$15.8MFY2012
$15.9MFY2011
Source:
  • SEC filingFiling detailsAccession 0001193805-12-000689
  • SEC filingFiling detailsAccession 0001213900-13-001814
· event Dec 31, 2012 · retrieved Jul 26, 2026 · annual-row source set
Embed this chart

Flagship explainer

Where TANKE BIOSCIENCES CORP's cash went

TANKE BIOSCIENCES CORP’s filing does not supply enough provenance-matched cash-flow lines for a truthful flow chart — here’s what is filed:

Table alternative
Filed lineValue% of cash from operationsSource
Cash from operations−$1.2M−100%
Depreciation and amortization$63628654%
Source: · event Dec 31, 2012 · retrieved Jul 26, 2026 · annual-row source set

Curated 19-manager tier

Who reported holding TANKE BIOSCIENCES CORP

Delayed public 13F reports for 2026-Q1—not live positions, trades, or recommendations.

0 holding0 exited0 not holding0/19 resolved19 unavailable

Named manager positions and quarter-over-quarter changes
ManagerReported positionQuarter-over-quarterFiling accession
Abrams CapitalUnavailableComparison unavailableFiling unavailable
Akre CapitalUnavailableComparison unavailableFiling unavailable
Baupost GroupUnavailableComparison unavailableFiling unavailable
Berkshire HathawayUnavailableComparison unavailableFiling unavailable
Brave Warrior AdvisorsUnavailableComparison unavailableFiling unavailable
Dodge & CoxUnavailableComparison unavailableFiling unavailable
First EagleUnavailableComparison unavailableFiling unavailable
FundsmithUnavailableComparison unavailableFiling unavailable
Gardner Russo & QuinnUnavailableComparison unavailableFiling unavailable
Gates Foundation TrustUnavailableComparison unavailableFiling unavailable
Mairs & PowerUnavailableComparison unavailableFiling unavailable
Markel / Markel-GaynerUnavailableComparison unavailableFiling unavailable
Oakmark / Harris AssociatesUnavailableComparison unavailableFiling unavailable
Pershing SquareUnavailableComparison unavailableFiling unavailable
Polen CapitalUnavailableComparison unavailableFiling unavailable
Sequoia / Ruane CunniffUnavailableComparison unavailableFiling unavailable
Southeastern Asset ManagementUnavailableComparison unavailableFiling unavailable
Tweedy, BrowneUnavailableComparison unavailableFiling unavailable
Yacktman Asset ManagementUnavailableComparison unavailableFiling unavailable

Position size uses shares and filed value from each manager’s 13F. Portfolio weight uses the eligible long-share filing denominator. Changes compare only with the immediately preceding calendar quarter.

Source: Filing source unavailable · event Mar 31, 2026 · retrieved Jul 26, 2026

Flagship explainer

What TANKE BIOSCIENCES CORP insiders reported

The complete Form 4 source snapshot retrieved on Aug 11, 2026 contains no transaction rows.

Verified empty: the retrieved source snapshot contains no transaction event.

Source snapshot retrieved 2026-08-11T07:00:13.245Z · SEC Form 4

Moat Score history

15 logged readings since Jul 17, 2026 · append-only, never rewritten

Moat Score over timeLast scored reading of each day, on the 0–100 scale59.1 / 100
0406080100WideNarrowShallowNo moatJul 17, 2026Jul 26, 2026

Breaks in the line mark methodology or normalizer upgrades — readings across versions aren’t compared, so a level shift there isn’t a change in the business.

Tier changesSame-methodology and same-normalizer crossings of the Wide / Narrow / Shallow bars

  1. Normalizer upgraded unstamped (version unknown)moat-xbrl-normalizer@1.1.0 — readings across versions aren’t comparedJul 26, 2026
  2. Methodology upgraded moat-index@2.0.0moat-index@3.0.0 — readings across versions aren’t comparedJul 23, 2026
  3. Methodology upgraded moat-index@1.2.0moat-index@2.0.0 — readings across versions aren’t comparedJul 20, 2026

Scores are logged append-only and never overwritten — this record cannot be reconstructed retroactively, which is exactly why it’s worth keeping.

Insider activity

Form 4 reports mix P/S market or private transactions with compensation-plan mechanics. Activity casually described as “insider selling” can include compensation mechanics; awards, tax withholding, and option exercises are shown by their exact filed class here, never collapsed into “Bought” or “Sold.”

These are disclosed filing facts and arithmetic aggregates, not a signal or verdict.

This machine-readable surface covers SEC ownership filings from 2003; it does not represent earlier paper-era records.

No reported Form 4 transactions were found in the complete checked issuer window for TNBI, –. The totals and cluster result below are arithmetic over that certified window.

$0
P purchases minus S sales only, Aug 11, 2025–Aug 11, 2026.
0 P / 0 S
Only P and S are included; awards, gifts, exercises, withholding, and other mechanics are excluded.
No
Requires at least 3 distinct insiders with P purchases.

Transaction-code histogram

Supporting event counts for the same certified window, Aug 11, 2025–Aug 11, 2026.

P
0
S
0
A
0
F
0
M
0
G
0
C
0
J
0
W
0

Retrieved .

Consumer Staples context

#23 of 85 scored Consumer Staples companies, ranked by Moat Score.

Nearest peers by Moat Score

  1. #21LWAY LIFEWAY FOODS, INC.63.6Narrow moat
  2. #22MED Medifast, Inc.62.2Narrow moat
  3. #24PPC PILGRIM’S PRIDE CORPORATION57.4Shallow moat
  4. #25SMPL The Simply Good Foods Company57.4Shallow moat

Compare TNBI with its nearest peers →All Consumer Staples companies on the Index →

Common questions about TNBI

Does TANKE BIOSCIENCES CORP have an economic moat?
Based on its FY2012 SEC filings, the Moat Index scores TANKE BIOSCIENCES CORP (TNBI) 59.1 out of 100 — a Shallow moat. The five questions behind that score begin at 20% each; if exactly one genuinely lacks data, the other four weights are renormalized and disclosed. revenue and EPS trend 50, pricing power 64, returns on capital 100, balance-sheet safety 58, capital allocation 24.
How has TNBI's Moat Score changed over time?
The record logs 15 readings since Jul 17, 2026; the latest reads 59.1 out of 100 (shallow moat). No tier changes on record yet. (Methodology or normalizer upgrades on Jul 20, 2026, Jul 23, 2026, Jul 26, 2026 re-based the score; readings across versions aren't compared.) The history is append-only — readings are only ever added, never rewritten.

Scored from primary SEC filings via the public methodology. Educational only — not a recommendation to buy or sell TNBI. See the disclaimer.